Skip to main content
Drug bottle and Pill

Compare Reyataz vs. Crixivan

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Atazanavir (Reyataz) and indinavir (Crixivan) are both medications used to treat HIV infections when taken with other HIV antiretrovirals. They both belong to the protease inhibitor class of antiretroviral (ARV) medications. However, there are several differences between them. Atazanavir (Reyataz) is still available and is taken orally, either as a tablet or powder, while indinavir (Crixivan) has been discontinued in the U.S. due to business reasons and the availability of newer treatments. Atazanavir (Reyataz) is typically taken once daily with food and often requires a "booster" like ritonavir to enhance its effectiveness. In contrast, indinavir (Crixivan) was known for its side effects and interactions, which contributed to its decline in use. Atazanavir (Reyataz) can cause side effects like nausea, headache, and jaundice, and it interacts with many medications, requiring careful management.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.